Core Insights - Kestra Medical Technologies, Ltd. is debuting its Cardiac Recovery System (CRS) platform at the 2025 Heart Failure Society of America Annual Scientific Meeting, highlighting its commitment to advancing care for heart failure patients [1][4]. Company Overview - Kestra Medical Technologies is a commercial-stage wearable medical device and digital healthcare company focused on improving patient outcomes in cardiovascular disease through intuitive, intelligent, and connected monitoring and therapeutic intervention technologies [5]. Product Features - The CRS platform includes the ASSURE Wearable Cardioverter Defibrillator, which aims to close the gap in sudden cardiac death protection by providing actionable insights during the early phase of heart failure recovery [2]. - Attendees at the conference can engage with the CRS platform through immersive experiences and hands-on demonstrations, showcasing its ability to empower clinicians and enhance patient-provider connections [3]. Industry Engagement - Kestra will also participate in the Devices in Heart Failure Meeting, allowing attendees to see the ASSURE system and understand its integration into clinical workflows to support guideline-directed medical therapy [4].